(Q36890928)

16 August 2017

title

Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic (English)

1 reference

16 August 2017

0 references

0 references

1 reference

Suissa S

1

1 reference

16 August 2017

Ernst P

series ordinal

2

1 reference

16 August 2017

publication date

1 October 1997

1 reference

Journal of Clinical Epidemiology

16 August 2017

published in

1 reference

16 August 2017

volume

50

1 reference

16 August 2017

issue

10

1 reference

16 August 2017

page(s)

1079-1088

1 reference

Variables on scatterplots look more highly correlated when the scales are increased

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Observations on recent increase in mortality from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Asthma deaths in New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

End of the New Zealand asthma mortality epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Asthma deaths in New Zealand: whodunnit?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

End of New Zealand asthma epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Asthma deaths in New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Asthma deaths in New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

International comparison of the prevalence of asthma symptoms and bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Uses of ecologic analysis in epidemiologic research

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Invited commentary: ecologic studies--biases, misconceptions, and counterexamples

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

On the estimation of relative risk from vital statistical data

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Confounding by indication and channeling over time: the risks of beta 2-agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Asthma mortality and inhaled beta agonist therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

Respiratory arrest in near-fatal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

The case-time-control design

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900158-3

7 January 2021

10.1016/S0895-4356(97)00158-3

Identifiers

DOI

1 reference

16 August 2017

1 reference